PDS Biotechnology
PDSB
A$1.94
Share price
4.10%
Change (1 day)
-59.42%
Change (1 year)
Categories
PDS Biotechnology (PDSB) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : A$37.76 Million
According to PDS Biotechnology 's latest financial reports the company's total liabilities are A$37.76 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
PDS Biotechnology - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | A$48.81 M | 0.65% |
| 2022-12-31 | A$48.5 M | 781.84% |
| 2021-12-31 | A$5.5 M | 12.45% |
| 2020-12-31 | A$4.89 M | 22.58% |
| 2019-12-31 | A$3.98 M | -55.96% |
| 2018-12-31 | A$9.05 M | -76.62% |
| 2017-12-31 | A$38.74 M | 29.08% |
| 2016-12-31 | A$30.01 M | 88.27% |
| 2015-12-31 | A$15.94 M | -70.8% |
| 2014-12-31 | A$54.59 M | 102.2% |
| 2013-12-31 | A$26.99 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | A$35.39 M | -6.27% | 🇺🇸 USA |